UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 146

Sortiert nach

The albumin‐bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV‐associated hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (1), p.95-103

2018

Volltextzugriff (PDF)

P558 IMPACT OF SCREENING ON SURVIVAL OF HEPATOCELLULAR CARCINOMA (HCC) IN HIV/HBV-COINFECTED PATIENTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S255-S255

2014

Volltextzugriff (PDF)

Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin

Journal of viral hepatitis, 2006-04, Vol.13 (4), p.242-249

2006

Volltextzugriff (PDF)

HIV infection adversely influences the natural history of untreated hepatocellular carcinoma (HCC)

Journal of hepatology, 2018-04, Vol.68, p.S431

2018

Volltextzugriff (PDF)

FRI-157 - HIV infection adversely influences the natural history of untreated hepatocellular carcinoma (HCC)

Journal of hepatology, 2018-04, Vol.68, p.S431-S431

2018

Volltextzugriff (PDF)

Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection

The American journal of gastroenterology, 2005-08, Vol.100 (8), p.1772-1779

2005

Volltextzugriff (PDF)

Can We Predict the Degree of Fibrosis in Chronic Hepatitis C Patients Using Routine Blood Tests in Our Daily Practice?

Journal of clinical gastroenterology, 2008-08, Vol.42 (7), p.827-834

2008

Volltextzugriff (PDF)

Treatment Eligibility and Outcomes in Elderly Patients with Chronic Hepatitis C: Results from the VA HCV-001 Study

Digestive diseases and sciences, 2008-03, Vol.53 (3), p.809-814

2008

Volltextzugriff (PDF)

Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York city metropolitan area

The American journal of gastroenterology, 2002-08, Vol.97 (8), p.2071-2078

2002

Volltextzugriff (PDF)

Crohnʼs disease in the setting of immunodeficiency with T-cell mediated immunoproliferative disorder: A case report: P-0032

Inflammatory bowel diseases, 2007-05, Vol.13, p.657

2007

Volltextzugriff (PDF)

Crohnʼs disease in the setting of immunodeficiency with T-cell mediated immunoproliferative disorder: A case report

Inflammatory bowel diseases, 2007-05, Vol.13 (supplement), p.657

2007

Volltextzugriff (PDF)

Pseudodementia from phenobarbital masking as encephalopathy in a PBC patient

The American journal of gastroenterology, 2001-09, Vol.96 (9), p.S176-S177

2001

Volltextzugriff (PDF)

Interstitial pneumonitis:a rare but potentially fatal comlication of combination therapy

The American journal of gastroenterology, 2003-09, Vol.98 (9), p.S210-S210

2003

Volltextzugriff (PDF)

Treatment response rates of U.S. veterans in Brooklyn with chronic hepatitis C infection

The American journal of gastroenterology, 2002-09, Vol.97 (9), p.S101-S101

2002

Volltextzugriff (PDF)

Severe migraine headaches are caused by ribavirin but not by interferon alpha-2B in combination therapy for chronic hepatitis C

Journal of hepatology, 2003-06, Vol.38 (6), p.871

2003

Volltextzugriff (PDF)

Sertraline induced hepatopathy in patients on Rebetron therapy

The American journal of gastroenterology, 2001-09, Vol.96 (9), p.S177-S177

2001

Volltextzugriff (PDF)

547 Host-virus interactions in acute hepatitis C

Hepatology (Baltimore, Md.), 2003, Vol.38, p.422-423

2003

Volltextzugriff (PDF)

Correlation of liver iron index (LII) to disease activity in patients with chronic hepatitis C

Gastroenterology (New York, N.Y. 1943), 1995-04, Vol.108 (4), p.A1027-A1027

1995

Volltextzugriff (PDF)

Interferon-alpha-2b and ribavirin for retreatment of chronic hepatitis C

Hepato-gastroenterology, 2002-05, Vol.49 (45), p.758

2002

Volltextzugriff (PDF)

Continuing Medical Education Questions: September 2021

The American journal of gastroenterology, 2021-09, Vol.116 (9), p.1831-1831

Aytaman, Ayse

2021

Volltextzugriff (PDF)

S1139 COVID-19 Experience in Patients With Cirrhosis and Clinically Significant Portal Hypertension

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S534-S535

2021

Volltextzugriff (PDF)

Obesity: The Forgotten Pandemic

The American journal of gastroenterology, 2022-01, Vol.117 (1), p.7-10

2022

Volltextzugriff (PDF)

Chronic Liver Disease in the Older Patient—Evaluation and Management

Current gastroenterology reports, 2023-12, Vol.25 (12), p.390-400

2023

Volltextzugriff (PDF)

Endoscopic and non-endoscopic approaches for the management of radiation-induced rectal bleeding

World journal of gastroenterology : WJG, 2016-08, Vol.22 (31), p.6972-6986

2016

Volltextzugriff (PDF)

Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database

Clinical gastroenterology and hepatology, 2015-12, Vol.13 (13), p.2333-2341.e6

2015

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(145)
Dissertationen
(1)

Sprache

Englisch
(146)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The albumin‐bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV‐associated hepatocellular carcinoma

P558 IMPACT OF SCREENING ON SURVIVAL OF HEPATOCELLULAR CARCINOMA (HCC) IN HIV/HBV-COINFECTED PATIENTS

Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin

HIV infection adversely influences the natural history of untreated hepatocellular carcinoma (HCC)

FRI-157 - HIV infection adversely influences the natural history of untreated hepatocellular carcinoma (HCC)

Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection

Can We Predict the Degree of Fibrosis in Chronic Hepatitis C Patients Using Routine Blood Tests in Our Daily Practice?

Treatment Eligibility and Outcomes in Elderly Patients with Chronic Hepatitis C: Results from the VA HCV-001 Study

Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York city metropolitan area

Crohnʼs disease in the setting of immunodeficiency with T-cell mediated immunoproliferative disorder: A case report: P-0032

Crohnʼs disease in the setting of immunodeficiency with T-cell mediated immunoproliferative disorder: A case report

Pseudodementia from phenobarbital masking as encephalopathy in a PBC patient

Interstitial pneumonitis:a rare but potentially fatal comlication of combination therapy

Treatment response rates of U.S. veterans in Brooklyn with chronic hepatitis C infection

Severe migraine headaches are caused by ribavirin but not by interferon alpha-2B in combination therapy for chronic hepatitis C

Sertraline induced hepatopathy in patients on Rebetron therapy

547 Host-virus interactions in acute hepatitis C

Correlation of liver iron index (LII) to disease activity in patients with chronic hepatitis C

Interferon-alpha-2b and ribavirin for retreatment of chronic hepatitis C

Continuing Medical Education Questions: September 2021

S1139 COVID-19 Experience in Patients With Cirrhosis and Clinically Significant Portal Hypertension

Obesity: The Forgotten Pandemic

Chronic Liver Disease in the Older Patient—Evaluation and Management

Endoscopic and non-endoscopic approaches for the management of radiation-induced rectal bleeding

Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database

Suchergebnisse filtern